


Ask a doctor about a prescription for DOXAZOSIN NEO TEVA-RATIOPHARM 4 mg PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the User
Doxazosina Neo Teva-ratiopharm 4 mg prolonged-release tablets EFG
doxazosina
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
Contents of the pack and further information
Your doctor has prescribed Doxazosina Neo Teva-ratiopharm because your blood pressure is high, which, if left untreated, increases the risk of heart disease or stroke. The active substance in your tablets, doxazosina, belongs to a group of medicines known as alpha-blockers. These drugs work by dilating blood vessels, making it easier for the heart to pump blood through them. This way, it is easier to reduce high blood pressure.
You may also have been prescribed Doxazosina Neo Teva-ratiopharm because you have an enlarged prostate (benign prostatic hyperplasia), which makes it difficult to urinate. The prostate is located just below the urine bladder in men. Doxazosina Neo Teva-ratiopharm works by relaxing the muscle that surrounds the bladder outlet and prostate, making it easier to urinate.
Do not take Doxazosina Neo Teva-ratiopharm
Warnings and precautions
Consult your doctor or pharmacist before starting to take Doxazosina Neo Teva-ratiopharm
At the start of treatment, you should avoid situations where injuries can occur as a result of dizziness or weakness, and in rare cases, fainting.
If you are going to undergo cataract surgery (clouding of the lens), please inform your ophthalmologist before the operation that you are using or have previously used Doxazosina Neo Teva-ratiopharm. This is because Doxazosina Neo Teva-ratiopharm can cause complications during surgery that can be controlled if your ophthalmologist is previously informed.
In Doxazosina Neo Teva-ratiopharm, the active substance is surrounded by an inert material, a non-absorbable coating designed to control the release of the substance over a prolonged period. After passing through the gastrointestinal tract, the empty tablet coating is separated. Do not worry if you occasionally see something in your stool that looks like a tablet.
Before starting treatment with Doxazosina Neo Teva-ratiopharm, your doctor may perform tests to rule out other diseases such as prostate cancer that can cause the same symptoms as benign prostatic hyperplasia.
Children and adolescents
Doxazosina Neo Teva-ratiopharm is not recommended for children or adolescents under 18 years of age, as safety and efficacy have not been established.
Other medicines and Doxazosina Neo Teva-ratiopharm
Always tell your doctor about the medicines you are taking. This includes any medicine you have bought yourself and those that have been prescribed by a doctor. Some medicines interact with Doxazosina Neo Teva-ratiopharm. These include:
Doxazosina Neo Teva-ratiopharm with food and drinks
Doxazosina Neo Teva-ratiopharm can be taken with or after food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Take Doxazosina Neo Teva-ratiopharm during pregnancy if it is prescribed by a doctor after careful evaluation of the benefit-risk.
Small amounts of doxazosina, the active substance of Doxazosina Neo Teva-ratiopharm, may appear in breast milk. You should not take Doxazosina Neo Teva-ratiopharm while breastfeeding your baby unless your doctor recommends it.
Driving and using machines
Doxazosina Neo Teva-ratiopharm can cause drowsiness. Be especially careful when taking the tablets for the first time. If drowsiness appears, do not drive or use heavy machinery.
Doxazosina Neo Teva-ratiopharm contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per prolonged-release tablet; this is essentially "sodium-free".
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The packaging will tell you how many tablets to take and when. You should swallow the tablets whole with a glass of water. Do not crush or chew them.
Adults andelderly
The dose of Doxazosina Neo Teva-ratiopharm is the same whether you take the medicine for high blood pressure or to treat the symptoms of benign prostatic hyperplasia. The recommended dose is one tablet per day. The optimal effect may take up to four weeks to achieve. Your doctor may increase your dose up to the maximum recommended dose of two tablets per day.
If you take more Doxazosina Neo Teva-ratiopharm than you should
If you take too many tablets, the most likely symptoms would be dizziness or lightheadedness due to low blood pressure. You should lie down on your back with your feet higher than your head. Contact the nearest emergency service or consult your doctor or pharmacist immediately. Bring this leaflet and any remaining tablets with you so that your doctor knows what you have taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount administered.
If you forget to take Doxazosina Neo Teva-ratiopharm
Try to take the tablets every day as prescribed. However, if you forget a dose, take it as soon as you remember. Do not take two doses at the same time.
If you stop taking Doxazosina Neo Teva-ratiopharm
Do not stop taking this medicine without consulting your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects that may occur (may affect up to 1 in 10 people) are:
Uncommon side effects that may occur (may affect up to 1 in 100 people) are:
Rare side effects (may affect up to 1 in 1,000 people) are:
Very rare side effects that may occur (may affect up to 1 in 10,000 people) are:
Side effects of unknown frequency (cannot be estimated from the available data) are:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after the abbreviation "EXP". The expiry date refers to the last day of the month shown.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help to protect the environment.
Composition of Doxazosina Neo Teva-ratiopharm
Each prolonged-release tablet contains 4.85 mg of doxazosina mesylate, which corresponds to 4 mg of doxazosina.
Appearance of the product andcontents of the pack
Doxazosina Neo Teva-ratiopharm 4 mg prolonged-release tablets are white, round, biconvex tablets with "DL" on one side.
They are available in PVC/PVDC/aluminum blister packs of 20, 28, 20, 50, 98, 100, and 500 prolonged-release tablets, (normal blister: 20, 30, 50, 100, 500; calendar blister: 28, 98; unit-dose blister: 30x1, 50x1, and 100x1).
Not all pack sizes may be marketed.
Marketing authorization holder
Teva Pharma, S.L.U.
C/Anabel Segura, 11 Edificio Albatros B, 1ª Planta
28108 Alcobendas, Madrid (Spain)
Manufacturer
Merckle GmbH
Ludwig Merckle Strasse, 3
89143 - Blaubeuren (Germany)
Date of last revision of this leaflet: September 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http: //www.aemps.gob.es/
You can access detailed information about this medicine by scanning the QR code included in the packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/66338/P_66338.html
QR code + URL
The average price of DOXAZOSIN NEO TEVA-RATIOPHARM 4 mg PROLONGED-RELEASE TABLETS in November, 2025 is around 7.27 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DOXAZOSIN NEO TEVA-RATIOPHARM 4 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.